| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A decade of letrozole: FACE
|
O’Shaughnessy, Joyce
|
|
2008
|
112 |
2 |
p. 373
|
artikel
|
| 2 |
A six-nucleotide deletion in the CASP8 promoter is not associated with a susceptibility to breast and prostate cancers in the Polish population
|
Cybulski, Cezary
|
|
2007
|
112 |
2 |
p. 367-368
|
artikel
|
| 3 |
Breast cancer risk and the BRCA1 interacting protein CTIP
|
Gorringe, Kylie L.
|
|
2007
|
112 |
2 |
p. 351-352
|
artikel
|
| 4 |
Circulating transforming growth factor-β-1 and breast cancer prognosis: results from the Shanghai Breast Cancer Study
|
Grau, Ana M.
|
|
2007
|
112 |
2 |
p. 335-341
|
artikel
|
| 5 |
Comprehensive analysis of oncogenic effects of PIK3CA mutations in human mammary epithelial cells
|
Zhang, Haijun
|
|
2007
|
112 |
2 |
p. 217-227
|
artikel
|
| 6 |
Dickkopf-1 mediated tumor suppression in human breast carcinoma cells
|
Mikheev, Andrei M.
|
|
2007
|
112 |
2 |
p. 263-273
|
artikel
|
| 7 |
Editorial
|
Mouridsen, Henning T.
|
|
2007
|
112 |
2 |
p. 381
|
artikel
|
| 8 |
Familial association of laryngeal, lung, stomach and early-onset breast cancer
|
Jaworowska, Ewa
|
|
2007
|
112 |
2 |
p. 359-361
|
artikel
|
| 9 |
Femara® and the future: tailoring treatment and combination therapies with Femara
|
Ellis, Matthew
|
|
2007
|
112 |
2 |
p. 383
|
artikel
|
| 10 |
Genetic analysis of BRCA1 and BRCA2 in breast/ovarian cancer families from Aragon (Spain): two novel truncating mutations and a large genomic deletion in BRCA1
|
Miramar, M. D.
|
|
2008
|
112 |
2 |
p. 353-358
|
artikel
|
| 11 |
Id-1 regulates Bcl-2 and Bax expression through p53 and NF-κB in MCF-7 breast cancer cells
|
Kim, Hwan
|
|
2007
|
112 |
2 |
p. 287-296
|
artikel
|
| 12 |
Letrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1-98
|
Koeberle, Dieter
|
|
2007
|
112 |
2 |
p. 387
|
artikel
|
| 13 |
Letrozole in the extended adjuvant setting: MA.17
|
Goss, Paul E.
|
|
2008
|
112 |
2 |
p. 369
|
artikel
|
| 14 |
Letrozole in the neoadjuvant setting the P024 trial
|
Ellis, Matthew J.
|
|
2007
|
112 |
2 |
p. 371
|
artikel
|
| 15 |
Pooled analysis of diarrhea events in patients with cancer treated with lapatinib
|
Crown, John P.
|
|
2008
|
112 |
2 |
p. 317-325
|
artikel
|
| 16 |
Reproducibility of ductal lavage cytology and cellularity over a six month interval in high risk women
|
Patil, Deepa B.
|
|
2007
|
112 |
2 |
p. 327-333
|
artikel
|
| 17 |
Results of a population-based screening for hereditary breast cancer in a region of North-Central Italy: contribution of BRCA1/2 germ-line mutations
|
Seymour, Ian J.
|
|
2007
|
112 |
2 |
p. 343-349
|
artikel
|
| 18 |
Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of α-difluoromethylornithine (DFMO) in breast cancer cells
|
Xu, Haifang
|
|
2007
|
112 |
2 |
p. 255-261
|
artikel
|
| 19 |
Safety of aromatase inhibitors in the adjuvant setting
|
Perez, Edith A.
|
|
2007
|
112 |
2 |
p. 379
|
artikel
|
| 20 |
Targeted disruption of Brca1 in restricted compartments of the mouse mammary epithelia
|
Smart, Chanel E.
|
|
2007
|
112 |
2 |
p. 237-241
|
artikel
|
| 21 |
The discovery and mechanism of action of letrozole
|
Bhatnagar, Ajay S.
|
|
2007
|
112 |
2 |
p. 385
|
artikel
|
| 22 |
The early days of letrozole
|
Bhatnagar, Ajay S.
|
|
2008
|
112 |
2 |
p. 377
|
artikel
|
| 23 |
The LCT 13910 C/T polymorphism as a risk factor for osteoporosis, has no impact on metastatic bone disease in breast cancer
|
Clar, H.
|
|
2007
|
112 |
2 |
p. 363-365
|
artikel
|
| 24 |
The patient experience
|
Harbeck, Nadia
|
|
2007
|
112 |
2 |
p. 375
|
artikel
|
| 25 |
The potential risk of neoadjuvant chemotherapy in breast cancer patients—results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07)
|
Taucher, Susanne
|
|
2007
|
112 |
2 |
p. 309-316
|
artikel
|
| 26 |
The thrombin inhibitor Argatroban reduces breast cancer malignancy and metastasis via osteopontin-dependent and osteopontin-independent mechanisms
|
Schulze, Erika B.
|
|
2007
|
112 |
2 |
p. 243-254
|
artikel
|
| 27 |
Towards an optimized platform for the detection, enrichment, and semi-quantitation circulating tumor cells
|
Molloy, T. J.
|
|
2008
|
112 |
2 |
p. 297-307
|
artikel
|
| 28 |
Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers
|
Walker, Logan C.
|
|
2007
|
112 |
2 |
p. 229-236
|
artikel
|
| 29 |
YKL-40 protein expression is not a prognostic marker in patients with primary breast cancer
|
Roslind, Anne
|
|
2007
|
112 |
2 |
p. 275-285
|
artikel
|
Tijdschrift beschrijving